Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
7 papers
Recent·Most cited
P. Gilchuk, C. D. Murin, R. W. Cross…·J. E. Crowe
This paper develops a therapeutic cocktail of two human antibodies that protect against multiple ebolaviruses in non-human primates and reveals their molecular mechanisms.
S. J. Zost, J. Dong, I. M. Gilchuk…·J. E. Crowe
The paper identifies common genetic and structural features of human antibodies recognizing the influenza HA trimer interface, suggesting it as a target for vaccine design.
A. R. Shiakolas, K. J. Kramer, D. Wrapp…·I. S. Georgiev
The paper identifies cross-reactive antibodies against multiple coronaviruses, showing they target diverse epitopes and mediate effector functions.
A. J. Greaney, T. N. Starr, P. Gilchuk…·J. D. Bloom
This study maps mutations in the SARS-CoV-2 spike RBD that escape antibody recognition, revealing escape mutation patterns and enabling the design of antibody cocktails.
S. J. Zost, P. Gilchuk, J. B. Case…·J. E. Crowe
The paper identifies potent neutralizing antibodies against SARS-CoV-2 that block receptor binding and protect animals, providing insights for vaccine and therapy development.
P. Gilchuk, R. G. Bombardi, J. H. Erasmus…·R. H. Carnahan
This study develops an integrated platform to rapidly discover and validate potent antiviral human monoclonal antibodies against Zika virus.
S. J. Zost, P. Gilchuk, R. Chen…·J. E. Crowe
This study isolates and profiles human monoclonal antibodies against SARS-CoV-2 spike protein, identifying neutralizing antibodies targeting the receptor-binding domain.